RxDoctor Payments Data

Helen Hobbs

Clinical Molecular Genetics · Dallas, TXNPI 1629177522

Payments from drug & device makers

$1,309,982in general payments, 2019–2025

Across 511 payments — averaging $2563.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1.3M
  • E.r. Squibb & Sons, L.L.C.$4K
  • Novo Nordisk$17

What the payments were for

  • Consulting fees$1,138,38687%
  • Travel & lodging$140,24711%
  • Food & beverage$30,8342%
  • Gifts$600%
  • Entertainment$4560%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer508$1,305,565
E.r. Squibb & Sons, L.L.C.2$4,400
Novo Nordisk1$17

How this compares

Too few clinical molecular genetics providers in Texasto place this figure against a meaningful peer group, so we don't.

Other clinical molecular genetics in Dallas

Where these figures come from

Is this you, or does something look wrong? →